Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Non Operating Income (2020 - 2025)

Cyclerion Therapeutics (CYCN) has 6 years of Non Operating Income data on record, last reported at $30000.0 in Q3 2025.

  • For Q3 2025, Non Operating Income fell 92.59% year-over-year to $30000.0; the TTM value through Sep 2025 reached $1.4 million, up 122.67%, while the annual FY2024 figure was $571000.0, 59.5% up from the prior year.
  • Non Operating Income reached $30000.0 in Q3 2025 per CYCN's latest filing, down from $1.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.3 million in Q2 2025 and bottomed at -$6000.0 in Q2 2021.
  • Average Non Operating Income over 5 years is $137526.3, with a median of $62000.0 recorded in 2023.
  • Peak YoY movement for Non Operating Income: tumbled 105.38% in 2021, then surged 13300.0% in 2022.
  • A 5-year view of Non Operating Income shows it stood at -$1000.0 in 2021, then soared by 13300.0% to $132000.0 in 2022, then dropped by 23.48% to $101000.0 in 2023, then plummeted by 72.28% to $28000.0 in 2024, then rose by 7.14% to $30000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $30000.0 in Q3 2025, $1.3 million in Q2 2025, and $28000.0 in Q1 2025.